Anzeige
Mehr »
Login
Samstag, 18.05.2024 Börsentäglich über 12.000 News von 688 internationalen Medien
Spezial Report: NASDAQ-FinTech mit 3.000% Wachstum und 500% Kurs-Chance!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

GlobeNewswire (Europe)-Archiv vom 15.03.2023

ZeitNachrichten
Sprache: Alle DE EN
LeserMedien
15.03.23Learning 2 Sleep L2S AB begins collaboration with Funmed AB, Europe's largest medical clinic in precision health and functional medicine335The digital healthcare provider Learning 2 Sleep L2S AB (L2S) has signed a cooperation agreement with the medical clinic Funmed AB (Funmed). The collaboration aims to provide effective treatment in...
► Artikel lesen
15.03.23Intchains Group Limited Announces Pricing of US$8.0 Million Initial Public Offering394Shanghai, China, March 15, 2023 (GLOBE NEWSWIRE) -- Intchains Group Limited (the "Company" or "Intchains Group"), a provider of integrated solutions consisting of high-performance ASIC chips and ancillary...
► Artikel lesen
15.03.23Yandex N.V. Notified of Anticipated Delisting from The Nasdaq Stock Market1.079NEW YORK, March 15, 2023 (GLOBE NEWSWIRE) -- The Nasdaq Stock Market (Nasdaq: NDAQ) announced today that it has notified Yandex N.V. (Nasdaq: YNDX) that its securities will be delisted from the Nasdaq...
► Artikel lesen
15.03.23Ozon Holdings PLC Notified of Anticipated Delisting from The Nasdaq Stock Market308NEW YORK, March 15, 2023 (GLOBE NEWSWIRE) -- The Nasdaq Stock Market (Nasdaq: NDAQ) announced today that it has notified Ozon Holdings PLC (Nasdaq: OZON) that its securities will be delisted from the...
► Artikel lesen
15.03.23QIWI PLC Notified of Anticipated Delisting from The Nasdaq Stock Market463NEW YORK, March 15, 2023 (GLOBE NEWSWIRE) -- The Nasdaq Stock Market (Nasdaq: NDAQ) announced today that it has notified QIWI PLC (Nasdaq: QIWI) that its securities will be delisted from the Nasdaq...
► Artikel lesen
15.03.23HeadHunter Group PLC Notified of Anticipated Delisting from The Nasdaq Stock Market340NEW YORK, March 15, 2023 (GLOBE NEWSWIRE) -- The Nasdaq Stock Market (Nasdaq: NDAQ) announced today that it has notified HeadHunter Group PLC (Nasdaq: HHR) that its securities will be delisted from...
► Artikel lesen
15.03.23The Bel Group: Bel: Annual Financial Information 2022 Results346Suresnes - March 15, 2023, at 6 p.m. Bel - Annual Financial Information 2022 Results A year of expansion and accelerationResilient financial performance in a high-inflation environment Resilient financial...
► Artikel lesen
15.03.23BioPorto A/S: BioPorto Provides a Business Update201March 15, 2023News release BioPorto Provides a Business Update COPENHAGEN, DENMARK and BOSTON, MA, March 15, 2023, (GLOBE NEWSWIRE) - BioPorto A/S (BioPorto or Company) (CPH:BIOPOR) today provided a...
► Artikel lesen
15.03.23Noranda Income Fund Announces Completion of Acquisition by Glencore337TORONTO, March 15, 2023 (GLOBE NEWSWIRE) -- Noranda Income Fund (TSX: NIF.UN) (the "Fund") today announced that the previously announced acquisition by Glencore Canada Corporation ("Glencore") of all...
► Artikel lesen
15.03.23Hyloris Pharmaceuticals SA: Hyloris reports full year results for 2022 & provides business outlook847Strong R&D progress & attractive commercial deals, including additional Tranexamic Acid RTU out-licensing dealsPotential U.S. market approval for Maxigesic® IV in H2 2023Promising new product candidates...
► Artikel lesen
15.03.23Alpha Teknova, Inc.: Teknova Reports Fourth Quarter and Full Year 2022 Financial Results241Full year 2022 total revenue was $41.4 million, up 12% year-over-yearNew, state-of-the-art manufacturing facility now operationalCompany provides 2023 revenue guidance of $42-46 million HOLLISTER, Calif....
► Artikel lesen
15.03.23Mineralys Therapeutics, Inc.: Mineralys Therapeutics Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Corporate Update908- Lorundrostat pivotal clinical program, for the treatment of patients with uncontrolled hypertension, expected to begin in the first half of 2023 - -IPO and Nasdaq listing completed in February 2023...
► Artikel lesen
15.03.23Vaxart, Inc.: Vaxart Provides Business Update and Full Year 2022 Financial Results739Prioritizing oral bivalent norovirus candidate, one of the most advanced norovirus vaccines in development Will continue preclinical development of novel COVID-19 vaccine constructs to enhance cross-reactivity...
► Artikel lesen
15.03.23Capricor Therapeutics Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Corporate Update743-Enrollment Continues to Progress in HOPE-3, the Phase 3 Clinical Trial of CAP-1002 in Duchenne Muscular Dystrophy (DMD); Plan to Report on Interim Analysis in Q4 2023- -Held Type-B CMC Meeting with...
► Artikel lesen
15.03.23MacroGenics, Inc.: MacroGenics Provides Corporate Update and 2022 Financial Results308Cash runway extended through 2025 with $250 million in non-dilutive funding over past eight months TAMARACK study design modified with objective of accelerating data readoutEncouraging lorigerlimab...
► Artikel lesen
15.03.23Five Below, Inc. Announces Fourth Quarter and Fiscal 2022 Financial Results278Q4 Net Sales Increase of 13%; Q4 Comparable Sales Increase of 1.9% Q4 EPS Increase of 23% to $3.07 PHILADELPHIA, March 15, 2023 (GLOBE NEWSWIRE) -- Five Below, Inc. (NASDAQ: FIVE) today announced...
► Artikel lesen
15.03.23RCM Technologies, Inc. Announces Fourth Quarter and Fiscal Year 2022 Results250PENNSAUKEN, N.J., March 15, 2023 (GLOBE NEWSWIRE) -- RCM Technologies, Inc. (NasdaqGM: RCMT), a premier provider of business and technology solutions designed to enhance and maximize the operational...
► Artikel lesen
15.03.23Brilliant Earth, LLC: Brilliant Earth Reports Fourth Quarter and Fiscal Year 2022 Results796Delivered 15.7% Net Sales Growth for Fiscal Year 2022 Generated Net Income of $19.0 million and Adjusted EBITDA of $39.0 million for Fiscal Year 2022 Generated Q4 GAAP Diluted EPS of $0.05 and Q4...
► Artikel lesen
15.03.23TAAT Global Alternatives Inc.: TAAT Provides Update on Status of MCTO478LAS VEGAS and VANCOUVER, British Columbia, March 15, 2023 (GLOBE NEWSWIRE) -- TAAT® GLOBAL ALTERNATIVES INC. (CSE: TAAT) (OTCQX: TOBAF) (FRANKFURT: 2TP) (the "Company" or "TAAT®") is providing this...
► Artikel lesen
15.03.23Kronos Bio, Inc.: Kronos Bio Reports Recent Business Progress and Fourth-Quarter and Full-Year 2022 Financial Results2.042First patient dosed in expansion portion of KB-0742 Phase 1/2 study, with initial efficacy results expected in 2H 2023 Recommended Phase 2 dose and initial data from Phase 1b/2 study of lanraplenib...
► Artikel lesen
Seite:  Weiter >>